ARCHIVES

Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Kea, Montes Leave DCPC; Smart Heads Early Detection Branch; Costlow Special Assistant

October 3, 1986

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

DCPC Board Oks Program To Encourage Produce Consumption

October 25, 1991

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977